Heidelberg Pharma AG (ETR:HPHA)
3.020
+0.090 (3.07%)
At close: Mar 27, 2026
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 114 employees as of August 31, 2025. The number of employees increased by 9 or 8.57% compared to the same quarter last year.
Employees
114
Change
9
Growth
8.57%
Revenue / Employee
€60,806
Profits / Employee
€370,889
Market Cap
141.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 114 | 9 | 8.57% |
| May 31, 2025 | 111 | 13 | 13.27% |
| Feb 28, 2025 | 105 | 7 | 7.14% |
| Nov 30, 2024 | 105 | 10 | 10.53% |
| Feb 29, 2024 | 98 | -2 | -2.00% |
| Nov 30, 2023 | 95 | -7 | -6.86% |
| Feb 28, 2023 | 100 | 11 | 12.36% |
| Nov 30, 2022 | 102 | 13 | 14.61% |
| May 31, 2022 | 93 | 6 | 6.90% |
| Feb 28, 2022 | 89 | 7 | 8.54% |
| Nov 30, 2021 | 89 | 11 | 14.10% |
| May 31, 2021 | 87 | 14 | 19.18% |
| Feb 28, 2021 | 82 | 10 | 13.89% |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,356 |
| Bayer Aktiengesellschaft | 87,280 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| MEDICLIN Aktiengesellschaft | 6,974 |
| Stratec SE | 1,420 |
| Medios AG | 999 |
| FamiCord AG | 766 |
Heidelberg Pharma AG News
- 1 day ago - Full Year 2025 Heidelberg Pharma AG Earnings Call Transcript - GuruFocus
- 18 days ago - EQS-AFR: Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 19 days ago - EQS-DD: Heidelberg Pharma AG: Dr. Birgit Kudlek, sell - Wallstreet:Online
- 22 days ago - EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital - Wallstreet:Online
- 4 months ago - EQS-News: Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer - Wallstreet:Online
- 4 months ago - EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer - Wallstreet:Online
- 5 months ago - EQS-News: Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma - Wallstreet:Online
- 5 months ago - EQS-News: Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar - Wallstreet:Online